Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
Pamela Gavin, Chief Executive Officer at National Organization for Rare Disorders (NORD), shared on LinkedIn:
”Today is Rare Disease Day.
1 in 10 Americans live with a rare disease.
That is not rare.
That is public health.
This year’s theme, ‘More Than You Can Imagine’, reflects the reality millions of families face: delayed diagnoses, limited treatments, fragile access.
- Rare disease is more complex than many realize.
- More costly.
- More interconnected than our systems are built to manage.
It is also more solvable than we are currently delivering.
Breakthrough science is accelerating.
Families should not have to wait for systems to catch up.
Progress depends on sustained NIH investment.
- A strong, fully staffed FDA.
- Policies that reward responsible innovation.
- Manufacturing that can scale.
- Coverage that ensures access.
A therapy approved is not a therapy accessed.
Rare disease is not niche. It is a national and global health priority hiding in plain sight and meeting this moment requires coordinated leadership across sectors.
For 17 years, NORD has served as the official U.S. sponsor of Rare Disease Day, in partnership with EURORDIS-Rare Diseases Europe and its alliance partners worldwide.
That role is both a privilege and a responsibility.
Today, we celebrate this community whose persistence has reshaped what is possible.
And we recommit to building the infrastructure, partnerships, and policy environment that turn breakthroughs into access and momentum into lasting progress.
More than you can imagine.
But not more than we can solve if we choose to build a system worthy of the community it serves.”

Stay updated with Hemostasis Today.
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis
-
Feb 28, 2026, 16:29Abdul Mannan: Evidence-Based Anticoagulation Strategies for Children With VTE
-
Feb 28, 2026, 16:28Pierre Sabouret: Exploring Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary Syndrome